Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06930846 · ClinicalTrials.gov registry record · NA

HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)

A NA study of Brain Tumor and Brain Cancer, sponsored by Dartmouth-Hitchcock Medical Center.

Recruiting
Registry status
NA
Development phase
125
Enrollment target
1
Study location

NCT06930846: Recruiting NA study of Brain Tumor and Brain Cancer, sponsored by Dartmouth-Hitchcock Medical Center.

NCT06930846 is a NA study of Brain Tumor and Brain Cancer that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 125 participants, below the 280-participant average among 69 other Brain Tumor trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06930846, a NA study of Brain Tumor and Brain Cancer, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.

RECRUITING
Registry status
NA
Development phase
125 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the ability of the home-based intervention, HOBSCOTCH-CA, to improve the quality of life and cognitive function in Service Members, Veterans and civilians who are survivors of brain cancer or a brain tumor (CA participants). This study will also assess the ability of the HOBSCOTCH-CA program to improve quality of life in caregivers of patients with brain cancer/tumor and to reduce caregiver burden. Enrolling with a Caregiver is optional for CA participants. Investigators will compare two groups of CA participants and their Caregiver (enrolling with a Caregiver is optional): one who receives HOBSCOCTCH-CA immediately (Group 1) and another group that will receive HOBSCOTCH-CA (Group 2) after a 3-month waiting period. Participants will be in the study for about 6 months total. HOBSCOTCH-CA involves 45 to 60 minute one on one virtual sessions with a certified Cognitive Coach including a "pre" program session and 8 weekly sessions thereafter. Participants will learn about problem solving therapy and mindfulness or relaxation training. CA participants are asked to do short homework assignments and keep a brief daily diary on a smart phone app. All participants complete study questionnaires or surveys at enrollment, 3 months later and at 6 months (at the end of the study).

Primary Outcome

The Neuro-QOL is a self-reported, validated assessment on health-related quality of life covering 17 domains in individuals with neurological disorders. Items are scored on a 5-point Likert scale that uses different language depending on assessment. The questions range from least (1) to most (5) based on frequency of behavior, amount of difficulty, or degree of agreement. Depending on the domain, a higher or lower score can indicate better or poorer quality of life for that domain.

Interventions

  • BEHAVIORAL HOBSCOTCH-CA

Study Locations (1)

New Hampshire

  • Dartmouth-Health Lebanon - Lebanon

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2025-11-03
Est. Completion 2028-12
Phase NA
Dartmouth-Hitchcock Medical Center

427 total trials

What NCT06930846 shows while recruiting

NCT06930846 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 280-participant average among 69 other Brain Tumor trials with a reported enrollment target (55% lower).

The record links to 10 conditions, with Brain Tumor appearing as the primary indexed condition, and to 1 intervention - of which HOBSCOTCH-CA is the first listed.

NCT06930846 reports a single indexed study location in New Hampshire.

Frequently Asked Questions

What is clinical trial NCT06930846 about?

NCT06930846 is a clinical study titled "HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)". The purpose of this study is to assess the ability of the home-based intervention, HOBSCOTCH-CA, to improve the quality of life and cognitive function in Service Members, Veterans and civilians who are survivors of brain cancer or a brain tumor (CA participants). This study will also assess the abil...

What is the current status of trial NCT06930846?

This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2025-11-03. Estimated completion is 2028-12.

What conditions does trial NCT06930846 study?

This clinical trial studies the following conditions: Brain Tumor, Brain Cancer, Cognitive Dysfunction, Low Grade Glioma, Meningioma.

What interventions are being tested in trial NCT06930846?

The interventions under investigation include: HOBSCOTCH-CA (BEHAVIORAL).

Who is sponsoring clinical trial NCT06930846?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06930846 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Brain Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06930846's enrollment target sits among peer trials

125 14th of 69 higher than 55 of 69 other Brain Tumor trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Brain Tumor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02717039 · 125 participants

    Pharmacogenomics of Heparin-Induced Thrombocytopenia

  • NCT02763033 · 125 participants · Phase 2

    Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients

  • NCT02793999 · 125 participants

    Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia

  • NCT03003299 · 125 participants · NA

    PARTNER 3 Trial - Aortic Valve-in-Valve

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06930846, the US trial registry maintained by the National Library of Medicine. NCT06930846 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.